Anacor Pharmaceuticals, Inc. 4
4 · Anacor Pharmaceuticals, Inc. · Filed Dec 10, 2014
Insider Transaction Report
Form 4
Maples Kirk R
Senior VP Program Mgt
Transactions
- Sale
Common Stock
2014-12-09$36.52/sh−40,104$1,464,734→ 4,800 total - Exercise/Conversion
Common Stock
2014-12-09$6.92/sh+19,896$137,680→ 24,696 total - Exercise/Conversion
Common Stock
2014-12-09$5.59/sh+40,104$224,181→ 44,904 total - Exercise/Conversion
Stock Option (right to buy)
2014-12-09$6.92/sh−19,896$137,680→ 18,208 totalExercise: $6.92Exp: 2021-03-31→ Common Stock (19,896 underlying) - Exercise/Conversion
Stock Option (right to buy)
2014-12-09$5.59/sh−40,104$224,181→ 14,896 totalExercise: $5.59Exp: 2022-03-13→ Common Stock (40,104 underlying) - Sale
Common Stock
2014-12-09$36.52/sh−19,896$726,670→ 4,800 total
Footnotes (3)
- [F1]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $36.40 to $36.80, inclusive.
- [F2]1/4 of the shares subject to the option shall vest and become exercisable on the 12 month anniversary of the Vesting Commencement Date and 1/48 of the shares subject to the option shall vest and become exercisable on each monthly anniversary thereafter. The Vesting Commencement Date is January 1, 2011.
- [F3]1/4 of the shares subject to the option shall vest and become exercisable on the 12 month anniversary of the Vesting Commencement Date and 1/48 of the shares subject to the option shall vest and become exercisable on each monthly anniversary thereafter. The Vesting Commencment Date is January 1, 2012.